Drug combination benefits patients with tophaceous gout
Saturday, June 10, 2017 - 15:22
in Health & Medicine
The drug lesinurad in combination with febuxostat was better at lowering blood levels of urate than febuxostat alone in a phase III clinical trial of 324 patients with tophaceous gout. Over 12 months, significantly more patients in the combination group achieved target levels of urate than patients in the febuxostat group.